# AnnotationID, ClassType, DocCharOnset(incl), DocCharOffset(excl), Text, Meta, Instances
0, Journal, 0, 21, "J Ocul Pharmacol Ther", "", "<http://ctro/data#Publication_53096> <http://ctro/data#hasJournal> \"J Ocul Pharmacol Ther\"."
1, PublicationYear, 24, 28, "2005", "", "<http://ctro/data#Publication_53096> <http://ctro/data#hasPublicationYear> \"2005\"."
2, Title, 56, 221, "The efficacy and safety of topical brinzolamide and dorzolamide when added to the combination therapy of latanoprost and a beta - blocker in patients with glaucoma .", "", "<http://ctro/data#Publication_53096> <http://ctro/data#hasTitle> \"The efficacy and safety of topical brinzolamide and dorzolamide when added to the combination therapy of latanoprost and a beta - blocker in patients with glaucoma .\"."
34845, Topic, 83, 90, "topical", "", 
3, Brinzolamide, 91, 103, "brinzolamide", "", 
4, Dorzolamide, 108, 119, "dorzolamide", "", 
5, Latanoprost, 161, 172, "latanoprost", "", 
34870, Drug, 179, 193, "beta - blocker", "", 
6, Glaucoma, 211, 219, "glaucoma", "", "<http://ctro/data#Glaucoma_53116> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#Glaucoma>. <http://ctro/data#ClinicalTrial_53107> <http://ctro/data#analysesHealthCondition> <http://ctro/data#Glaucoma_53116>."
76, Author, 222, 233, "Tsukamoto H", "", "<http://ctro/data#Publication_53096> <http://ctro/data#hasAuthor> \"Tsukamoto H\"."
77, Author, 242, 248, "Noma H", "", "<http://ctro/data#Publication_53096> <http://ctro/data#hasAuthor> \"Noma H\"."
78, Author, 251, 262, "Matsuyama S", "", "<http://ctro/data#Publication_53096> <http://ctro/data#hasAuthor> \"Matsuyama S\"."
79, Author, 265, 272, "Ikeda H", "", "<http://ctro/data#Publication_53096> <http://ctro/data#hasAuthor> \"Ikeda H\"."
80, Author, 275, 285, "Mishima HK", "", "<http://ctro/data#Publication_53096> <http://ctro/data#hasAuthor> \"Mishima HK\"."
7, Japan, 439, 444, "Japan", "", "<http://ctro/data#Population_53124> <http://ctro/data#hasCountry> <http://ctro/data#Japan>."
9, Brinzolamide, 490, 502, "Brinzolamide", "", 
10, Dorzolamide, 507, 518, "dorzolamide", "", 
8, ObjectiveDescription, 587, 796, "The purpose of this study was to compare the efficacy and safety of brinzolamide 1 % versus dorzolamide 1 % when added to the combination therapy of latanoprost and a beta - blocker in patients with glaucoma .", "", "<http://ctro/data#ClinicalTrial_53107> <http://ctro/data#hasObjectiveDescription> \"The purpose of this study was to compare the efficacy and safety of brinzolamide 1 % versus dorzolamide 1 % when added to the combination therapy of latanoprost and a beta - blocker in patients with glaucoma .\"."
11, Brinzolamide, 655, 667, "brinzolamide", "", 
13, DoseValue, 668, 669, "1", "", 
14, Percentage, 670, 671, "%", "", 
12, Dorzolamide, 679, 690, "dorzolamide", "", 
16, DoseValue, 691, 692, "1", "", 
15, Percentage, 693, 694, "%", "", 
17, Latanoprost, 736, 747, "latanoprost", "", 
37053, Drug, 754, 768, "beta - blocker", "", 
18, Glaucoma, 786, 794, "glaucoma", "", 
81, Duration, 810, 818, "8 - week", "", "<http://ctro/data#ClinicalTrial_53107> <http://ctro/data#hasCTduration> \"8 - week\"."
19, Randomized, 821, 831, "randomized", "", "<http://ctro/data#ClinicalTrial_53107> <http://ctro/data#hasCTDesign> <http://ctro/data#Randomized>."
20, OpenLabel, 834, 846, "open - label", "", "<http://ctro/data#ClinicalTrial_53107> <http://ctro/data#hasCTDesign> <http://ctro/data#OpenLabel>."
21, NumberPatientsCT, 882, 884, "52", "", "<http://ctro/data#ClinicalTrial_53107> <http://ctro/data#hasNumberPatientsCT> \"52\"."
22, Glaucoma, 899, 907, "glaucoma", "", 
23, Brinzolamide, 910, 922, "Brinzolamide", "", "<http://ctro/data#Medication_53172> <http://ctro/data#hasDrug> <http://ctro/data#Brinzolamide>."
24, DoseValue, 923, 924, "1", "", "<http://ctro/data#Medication_53172> <http://ctro/data#hasDoseValue> \"1\"."
25, Percentage, 925, 926, "%", "", "<http://ctro/data#Medication_53172> <http://ctro/data#hasDoseUnit> <http://ctro/data#Percentage>."
26, Frequency, 929, 940, "twice a day", "", "<http://ctro/data#Intervention_53160> <http://ctro/data#hasFrequency> \"twice a day\"."
27, Dorzolamide, 946, 957, "dorzolamide", "", "<http://ctro/data#Medication_53179> <http://ctro/data#hasDrug> <http://ctro/data#Dorzolamide>."
28, DoseValue, 958, 959, "1", "", "<http://ctro/data#Medication_53179> <http://ctro/data#hasDoseValue> \"1\"."
29, Percentage, 960, 961, "%", "", "<http://ctro/data#Medication_53179> <http://ctro/data#hasDoseUnit> <http://ctro/data#Percentage>."
30, Frequency, 964, 977, "3 times a day", "", "<http://ctro/data#Intervention_53166> <http://ctro/data#hasFrequency> \"3 times a day\"."
31, Randomized, 984, 992, "randomly", "", 
34862, Precondition, 1013, 1082, "patients who had been treated with both latanoprost and a betablocker", "", "<http://ctro/data#Population_53124> <http://ctro/data#hasPrecondition> \"patients who had been treated with both latanoprost and a betablocker\"."
32, Latanoprost, 1053, 1064, "latanoprost", "", 
34861, Drug, 1071, 1082, "betablocker", "", 
33, IOP, 1095, 1115, "Intraocular pressure", "", "<http://ctro/data#IOP_53133> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#IOP>. <http://ctro/data#Endpoint_53132> <http://ctro/data#hasEndoPointDescription> <http://ctro/data#IOP_53133>."
34, IOP, 1118, 1121, "IOP", "", 
35, PValueChangeValue, 1160, 1172, "P < 0 . 0001", "", "<http://ctro/data#Outcome_53186> <http://ctro/data#hasPValueChangeValue> \"P < 0 . 0001\". <http://ctro/data#Outcome_53213> <http://ctro/data#hasPValueChangeValue> \"P < 0 . 0001\"."
36, BaseLineValue, 1180, 1186, "18 . 6", "", "<http://ctro/data#Outcome_53186> <http://ctro/data#hasBaselineValue> \"18 . 6\"."
34863, SdDevBL, 1193, 1198, "2 . 3", "", "<http://ctro/data#Outcome_53186> <http://ctro/data#hasSdDevBL> \"2 . 3\"."
37, mmHg, 1199, 1203, "mmHg", "", 
39, ResultMeasuredValue, 1207, 1213, "16 . 7", "", "<http://ctro/data#Outcome_53186> <http://ctro/data#hasResultMeasuredValue> \"16 . 7\"."
34864, SdDevResValue, 1220, 1225, "2 . 3", "", "<http://ctro/data#Outcome_53186> <http://ctro/data#hasSdDevResValue> \"2 . 3\"."
38, mmHg, 1226, 1230, "mmHg", "", 
40, BaseLineValue, 1240, 1246, "18 . 4", "", "<http://ctro/data#Outcome_53213> <http://ctro/data#hasBaselineValue> \"18 . 4\"."
34865, SdDevBL, 1253, 1258, "2 . 6", "", "<http://ctro/data#Outcome_53213> <http://ctro/data#hasSdDevBL> \"2 . 6\"."
41, mmHg, 1259, 1263, "mmHg", "", 
42, ResultMeasuredValue, 1267, 1273, "16 . 6", "", "<http://ctro/data#Outcome_53213> <http://ctro/data#hasResultMeasuredValue> \"16 . 6\"."
34866, SdDevResValue, 1280, 1285, "2 . 5", "", "<http://ctro/data#Outcome_53213> <http://ctro/data#hasSdDevResValue> \"2 . 5\"."
43, mmHg, 1286, 1290, "mmHg", "", "<http://ctro/data#Endpoint_53132> <http://ctro/data#hasBaselineUnit> <http://ctro/data#mmHg>."
136, TimePoint, 1308, 1315, "8 weeks", "", "<http://ctro/data#Outcome_53186> <http://ctro/data#hasTimePoint> \"8 weeks\". <http://ctro/data#Outcome_53213> <http://ctro/data#hasTimePoint> \"8 weeks\"."
44, Brinzolamide, 1338, 1350, "brinzolamide", "", 
45, Dorzolamide, 1354, 1365, "dorzolamide", "", 
50, PvalueDiff, 1434, 1444, "P = 0 . 86", "", "<http://ctro/data#DiffBetweenGroups_53353> <http://ctro/data#hasPvalueDiff> \"P = 0 . 86\"."
34867, EndPointDescription, 1466, 1483, "ocular irritation", "AdverseEffect", "<http://ctro/data#EndPointDescription_53138> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#EndPointDescription>. <http://ctro/data#Endpoint_53137> <http://ctro/data#hasEndoPointDescription> <http://ctro/data#EndPointDescription_53138>."
142, PvalueDiff, 1511, 1523, "P < 0 . 0001", "", "<http://ctro/data#DiffBetweenGroups_53362> <http://ctro/data#hasPvalueDiff> \"P < 0 . 0001\"."
52, Dorzolamide, 1533, 1544, "dorzolamide", "", 
53, PercentageAffected, 1553, 1555, "74", "", "<http://ctro/data#Outcome_53267> <http://ctro/data#hasPercentageAffected> \"74\"."
54, Brinzolamide, 1569, 1581, "brinzolamide", "", 
55, PercentageAffected, 1590, 1592, "16", "", "<http://ctro/data#Outcome_53240> <http://ctro/data#hasPercentageAffected> \"16\"."
92865, BlurredVison, 1642, 1656, "blurred vision", "", "<http://ctro/data#Endpoint_53294> <http://ctro/data#hasEndoPointDescription> <http://ctro/data#BlurredVison>."
56, Dorzolamide, 1678, 1689, "dorzolamide", "", 
58, PercentageAffected, 1690, 1692, "37", "", "<http://ctro/data#Outcome_53326> <http://ctro/data#hasPercentageAffected> \"37\"."
57, Brinzolamide, 1702, 1714, "brinzolamide", "", 
59, PercentageAffected, 1715, 1717, "52", "", "<http://ctro/data#Outcome_53299> <http://ctro/data#hasPercentageAffected> \"52\"."
152, PvalueDiff, 1722, 1732, "P = 0 . 40", "", "<http://ctro/data#DiffBetweenGroups_53371> <http://ctro/data#hasPvalueDiff> \"P = 0 . 40\"."
61, ConclusionComment, 1751, 1991, "We concluded that the efficacy of brinzolamide 1 % was equivalent to dorzolamide 1 % ; however , the safety of brinzolamide 1 % was superior to dorzolamide 1 % as adjunctive therapy to the combination with latanoprost and a beta - blocker .", "", "<http://ctro/data#ClinicalTrial_53107> <http://ctro/data#hasConclusionComment> \"We concluded that the efficacy of brinzolamide 1 % was equivalent to dorzolamide 1 % ; however , the safety of brinzolamide 1 % was superior to dorzolamide 1 % as adjunctive therapy to the combination with latanoprost and a beta - blocker .\"."
62, Brinzolamide, 1785, 1797, "brinzolamide", "", 
67, DoseValue, 1798, 1799, "1", "", 
71, Percentage, 1800, 1801, "%", "", 
63, Dorzolamide, 1820, 1831, "dorzolamide", "", 
68, DoseValue, 1832, 1833, "1", "", 
72, Percentage, 1834, 1835, "%", "", 
64, Brinzolamide, 1862, 1874, "brinzolamide", "", 
69, DoseValue, 1875, 1876, "1", "", 
73, Percentage, 1877, 1878, "%", "", 
65, Dorzolamide, 1895, 1906, "dorzolamide", "", 
70, DoseValue, 1907, 1908, "1", "", 
74, Percentage, 1909, 1910, "%", "", 
66, Latanoprost, 1957, 1968, "latanoprost", "", 
34869, Drug, 1975, 1989, "beta - blocker", "", 
75, PMID, 2039, 2047, "15857284", "", "<http://ctro/data#Publication_53096> <http://ctro/data#hasPMID> \"15857284\"."
